Related references
Note: Only part of the references are listed.Prognosis After Ipsilateral Breast Tumor Recurrence and Locoregional Recurrences in Patients Treated by Breast-Conserving Therapy in Five National Surgical Adjuvant Breast and Bowel Project Protocols of Node-Negative Breast Cancer
Stewart J. Anderson et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Current concepts: Local therapy and survival in breast cancer
Rinaa S. Punglia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Tutorial in biostatistics: Competing risks and multi-state models
H. Putter et al.
STATISTICS IN MEDICINE (2007)
When can a second conservative approach be considered for ipsilateral breast tumour recurrence?
O. Gentilini et al.
ANNALS OF ONCOLOGY (2007)
The evolution of the conservative approach to breast cancer
Alberto Luini et al.
BREAST (2007)
Sentinel-lymph-node biopsy as a staging procedure in breast cancer:: update of a randomised controlled study
Umberto Veronesi et al.
LANCET ONCOLOGY (2006)
Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five national surgical adjuvant breast and bowel project node-positive adjuvant breast cancer trials
IL Wapnir et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Conservative treatment of breast cancer: its evolution
A Luini et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Classifying local disease recurrences after breast conservation therapy based on location and histology - New primary tumors have more favorable outcomes than true local disease recurrences
E Huang et al.
CANCER (2002)
Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer
B Fisher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer
U Veronesi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial
JA van Dongen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
